Plain-English translation of NCT07265323 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing a new way to deliver insulin to see if it can help people with Alzheimer's disease think more clearly and improve how their body handles blood sugar. Insulin is a natural hormone your body makes to help control glucose (blood sugar), but researchers believe that giving it in a special way might help protect brain function. The study will also check whether this treatment is safe and how it affects glucose use in the brain.
Recent research suggests that problems with how the body uses insulin and glucose may be connected to memory loss and thinking problems in Alzheimer's disease. This trial is testing whether this treatment could be a new way to slow or improve these symptoms.
You likely qualify if…
You likely don't qualify if…
You would visit the research center once a week for six months to receive the insulin infusion, with each visit lasting up to two hours. During the study, you'll complete memory and thinking tests, and researchers will monitor you for any side effects. The frequency of visits may decrease over time depending on how you respond to the treatment.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
United States